ARTICLE | Clinical News
Cordycepin, 3'-deoxyadenosine, and pentostatin, 2-deoxycoformycin: Update
January 13, 1997 8:00 AM UTC
Oxigene Inc. (OXGN), New York, N.Y. Product: Cordycepin, 3'-deoxyadenosine, and pentostatin, 2-deoxycoformycin Indication: Refractory TdT-positive, acute lymphoid leukemia Status: A Phase I trial of t...